Nefiracetam Tablets

Nefiracetam Tablets

Nefiracetam

• CAS Number: 77191-36-7​
• Molar Mass: 246.31 g·mol⁻¹​
• Chemical Formula: C₁₄H₁₈N₂O₂​
• IUPAC Name: N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide​

Introduction

Nefiracetam Tablets are a dedicated research product developed exclusively for scientific exploration, clearly not intended for human consumption. These tablets serve as valuable tools for researchers investigating the unique properties and potential benefits of nefiracetam across various research domains.​

Key Characteristics

Nefiracetam is a member of the racetam class of nootropics recognized for its potential cognitive-enhancing properties. It has garnered attention for its pharmacological characteristics and its impact on various aspects of cognitive function.​

Research Applications

Nefiracetam Tablets find diverse applications in research, offering researchers tools to explore the potential benefits of nefiracetam. Its applications include investigations into cognitive enhancement, depression, and visual acuity.​

Research Benefits

​Nefiracetam and Cognitive Enhancement

Studies suggest that nefiracetam may have cognitive-enhancing effects, particularly in memory and learning. Research in this area aims to uncover the mechanisms of action and applications in addressing cognitive deficits.​

​Nefiracetam and Depression

Preliminary research indicates that nefiracetam may have antidepressant properties, influencing mood regulation. Investigations into its effects on depressive symptoms contribute to understanding its applications in addressing mood disorders.​

​Nefiracetam and Visual Acuity

Research suggests that nefiracetam may affect visual acuity and perception. Studies exploring its effects on visual function contribute to understanding its applications in vision-related research.​

Summary

Nefiracetam Tablets, designed exclusively for research purposes, provide researchers with a unique avenue for investigating the potential benefits of nefiracetam in cognitive enhancement, depression, and visual acuity. The unique characteristics of nefiracetam make it a promising subject for further exploration in neuroscience and psychological research.​

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.​

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).​

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.​

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer satisfaction is our primary concern. If you are dissatisfied with the product received, please contact us at 419-707-5450 or email our support team at support@bc9.co.​

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Yamada, K., Tanaka, T., Mamiya, T., Shiotani, T., Kameyama, T. and Nabeshima, T. (1999), Improvement by nefiracetam of β-amyloid-(1-42)-induced learning and memory impairments in rats. British Journal of Pharmacology, 126: 235-244. https://doi.org/10.1038/sj.bjp.0702309 [Read More].
2. Double-Blind Randomized Treatment of Poststroke Depression Using Nefiracetam. Robert G. Robinson M.D.Ricardo E. Jorge M.D.Kathleen Clarence Smith M.D., Ph.D. Published Online:1 Apr 2008. [Read More].